Edition:
United States

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.73
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,298
52-wk High
$4.15
52-wk Low
$1.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.237
Jun '17 0.00 -0.305
Mar '17 0.00 -0.241
FY 2016 Dec '16 0.28 -0.820
Sep '16 0.00 -0.564
Jun '16 0.00 -0.762
Mar '16 0.45 -1.078
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.75 0.75 0.75 0.75
Earnings (per share)
Year Ending Dec-18 1 -0.65 -0.65 -0.65 -2.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 49.98 34.59
P/E High - Last 5 Yrs. -- 41.33 45.93
P/E Low - Last 5 Yrs. -- 21.07 24.19
Beta -- 0.80 0.81
Price to Sales (TTM) 60.13 7.42 8.08
Price to Book (MRQ) 0.74 14.30 5.24
Price to Tangible Book (MRQ) 4.49 22.86 6.43
Price to Cash Flow (TTM) -- 23.53 25.98
% Owned Institutions 65.94 4.54 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.96 1.52
Dividend Yield - 5 Year Avg -- 1.15 2.01
Dividend 5 Year Growth Rate -- 17.47 5.21
Payout Ratio(TTM) -- 59.37 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 14.37 9.76
Sales (TTM) vs TTM 1 Yr. Ago -58.32 10.93 7.61
Sales - 5 Yr. Growth Rate -- 8.95 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 57.97 73.68 18.78
EPS (TTM) vs TTM 1 Yr. Ago 53.98 -- --
EPS - 5 Yr. Growth Rate -- 19.75 11.55
Capital Spending - 5 Yr. Growth Rate -- 9.65 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.42 2.42
Current Ratio (MRQ) 3.69 3.20 3.39
LT Debt to Equity (MRQ) 0.00 28.38 12.18
Total Debt to Equity (MRQ) 0.00 32.38 15.60
Interest Coverage (TTM) -- 20.62 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 8.16 57.99 54.74
Gross Margin - 5 Yr. Avg. -- 57.54 52.50
EBITD Margin (TTM) -3,253.58 -- --
EBITD - 5 Yr. Avg -- 23.16 14.67
Operating Margin (TTM) -3,624.21 18.67 4.40
Operating Margin - 5 Yr. Avg. -- 15.89 9.99
Pre-Tax Margin (TTM) -3,693.15 18.31 5.14
Pre-Tax Margin - 5 Yr. Avg. -- 16.09 10.24
Net Profit Margin (TTM) -3,700.69 13.89 1.86
Net Profit Margin - 5 Yr. Avg. -- 11.20 6.55
Effective Tax Rate (TTM) -- 23.13 21.87
Effective Tax Rate - 5 Yr. Avg. -- 29.01 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 29,119,724 823,803,020
Net Income/Employee (TTM) -- 3,660,664 96,327,335
Receivable Turnover (TTM) 4.20 4.89 5.44
Inventory Turnover (TTM) -- 3.05 3.52
Asset Turnover (TTM) 0.02 0.76 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.40 10.62 10.76
Return on Assets - 5 Yr. Avg. -- 8.94 12.05
Return on Investment (TTM) -68.31 14.18 13.67
Return on Investment - 5 Yr. Avg. -- 11.67 15.78
Return on Equity (TTM) -73.65 16.80 15.40
Return on Equity - 5 Yr. Avg. -- 14.10 17.04
  1 Year 3 Year 5 Year
Sales % 138.82 -21.51 --
EPS (TTM) % 39.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Soleno Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.94%
# of Holders: 19
Total Shares Held: 12,685,382
3 Mo. Net Change: 5,879,948
# New Positions: 5
# Closed Positions: 8
# Increased Positions: 10
# Reduced Positions: 10
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.